闫永彬基于“邪伏肺络”论治儿童流感病毒性肺炎经验
Yan Yongbin's experience in treating pediatric influenza viral pneumonia based on the theory of pathogen latency in the lung collaterals
儿童流感病毒性肺炎以发热、咳嗽、气喘、呼吸困难为主要表现,属中医“肺风痰喘”范畴。闫永彬基于“邪伏肺络”理论认为,风邪引动,伏邪始发,肺络郁闭为发病之始;伏热酿毒,痰瘀互结,肺络闭阻为病进之由;正虚邪恋,耗气伤阴,肺络失养为病理转归。临证强调分期辨治,初期选用自拟宣肺透邪汤疏风透邪、宣通肺络,极期予麻杏石甘汤合苇茎汤化裁化痰祛瘀、通络开闭,恢复期予自拟肺炎恢复方扶正祛邪、荣养肺络,以期为儿童流感病毒性肺炎的中医药治疗提供参考。
Childhood influenza viral pneumonia, characterized by fever, cough, wheezing, and dyspnea, falls under the category of "wind-phlegm dyspnea of the lung" in traditional Chinese medicine. Based on the theory of "latent pathogens lurking in lung collaterals," Yan Yongbin proposes that the onset of the disease begins with wind pathogens triggering the release of latent pathogens, leading to lung collateral stagnation; disease progression is driven by latent heat generating toxins and the mutual binding of phlegm and stasis, obstructing lung collaterals; and the pathological outcome involves deficiency of healthy qi with lingering pathogens, consuming qi and injuring yin, resulting in malnourishment of lung collaterals. Clinically, he emphasizes staged treatment based on syndrome differentiation: in the early stage, self-formulated Xuanfei Touxie Decoction is used to dispel wind, expel latent pathogen, and unblock lung collaterals; in the acute stage, modified Maxing Shigan Decoction combined with Weijing Decoction resolves phlegm, removes stasis, and opens collateral obstruction; in the recovery stage, self-formulated Pneumonia Recovery Formula strengthens healthy qi, eliminates residual pathogen, and nourishes lung collaterals. This approach aims to provide a reference for TCM treatment of childhood influenza viral pneumonia.
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
刘彬果,吴葆婷,王剑丽, |
| [5] |
谭丽萍,李亚军,林艳, |
| [6] |
王琦.伏邪理论的学术内涵及临床指导价值[J].中医杂志,2025,66(24):2517-2522. |
| [7] |
孙君阳,肖静静,李蒋凤, |
| [8] |
王燕昌.王氏医存[M].南京:江苏科学技术出版社,1983. |
| [9] |
卢志远,王雨涵,戴启刚, |
| [10] |
梁元钰,袁佺,吕晓东, |
| [11] |
袁斌,白晓红,陈华, |
| [12] |
王焘.外台秘要[M].北京:人民卫生出版社,1955. |
| [13] |
陈金凤,何军,徐涛.基于流感发病机制的药物研究进展[J].中国药理学通报,2021,37(5):606-612. |
| [14] |
沈金鳌 .杂病源流犀烛[M].北京:人民卫生出版社,2006. |
| [15] |
王子威,马兰,刘晓红, |
| [16] |
傅梦薇,李洪峥,王阶.痰瘀互结证之理论与研究[J].时珍国医国药,2021,32(12):2977-2980. |
| [17] |
朱震亨.局方发挥[M].北京:人民卫生出版社,1956. |
| [18] |
马延贺,张洪.病毒性肺炎的病理机制与影像表现[J].国际医学放射学杂志,2023,46(5):591-597. |
| [19] |
徐哲,赵磊,姜天俊, |
| [20] |
褚天保,张庆.病毒性肺炎与机体凝血功能的相互影响研究[J].中国现代医药杂志,2024,26(12):97-103. |
| [21] |
刘金凤,崔佳旗,田传玺, |
| [22] |
陆子贤,山东中医学院文献研究室.六因条辨3卷[M].济南:山东科学技术出版社,1982. |
| [23] |
|
| [24] |
崔冰慧,郑旭锐.叶天士“久病入络”学术思想及络治法探析[J].中医学报,2020,35(1):59-62. |
| [25] |
张雪琦,赵亚格,闫永彬, |
国家重点研发计划项目(2024YFC3506000)
2025年新发突发与重大传染病防控国家科技重大专项(2025ZD01902904)
国家中医药管理局呼吸道感染性疾病应急专项项目(2023ZYLCYJO5-04)
/
| 〈 |
|
〉 |